<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(4)</volume><submitter>Quintens C</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Early switch from intravenous to oral therapy of bioequivalent drugs has major advantages but remains challenging. At our hospital, a basic clinical rule was designed to automatically alert the physician to review potential intravenous to oral switch (IVOS). A rather low acceptance rate was observed. In this study, we aimed to develop, validate and investigate the effect of more advanced clinical rules for IVOS, as part of a centralised pharmacist-led medication review service.&lt;h4>Design and setting&lt;/h4>A quasi-experimental study was performed in a large teaching hospital in Belgium using an interrupted time series design.&lt;h4>Intervention&lt;/h4>A definite set of 13 criteria for IVOS, focusing on the ability of oral absorption and type of infection, was obtained by literatu</pubmed_abstract><journal>BMJ open</journal><pagination>e053010</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8995958</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis.</pubmed_title><pmcid>PMC8995958</pmcid><pubmed_authors>Declercq P</pubmed_authors><pubmed_authors>Coenen M</pubmed_authors><pubmed_authors>Quintens C</pubmed_authors><pubmed_authors>Peetermans WE</pubmed_authors><pubmed_authors>Spriet I</pubmed_authors><pubmed_authors>Casteels M</pubmed_authors></additional><is_claimable>false</is_claimable><name>From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis.</name><description>&lt;h4>Objectives&lt;/h4>Early switch from intravenous to oral therapy of bioequivalent drugs has major advantages but remains challenging. At our hospital, a basic clinical rule was designed to automatically alert the physician to review potential intravenous to oral switch (IVOS). A rather low acceptance rate was observed. In this study, we aimed to develop, validate and investigate the effect of more advanced clinical rules for IVOS, as part of a centralised pharmacist-led medication review service.&lt;h4>Design and setting&lt;/h4>A quasi-experimental study was performed in a large teaching hospital in Belgium using an interrupted time series design.&lt;h4>Intervention&lt;/h4>A definite set of 13 criteria for IVOS, focusing on the ability of oral absorption and type of infection, was obtained by literatu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-05T22:17:06.933Z</modification><creation>2025-04-05T22:17:06.933Z</creation></dates><accession>S-EPMC8995958</accession><cross_references><pubmed>35396281</pubmed><doi>10.1136/bmjopen-2021-053010</doi></cross_references></HashMap>